CME Group (NASDAQ:CME) 株価情報

CME Group

CME Gr

Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.

CME Group Inc

COMPUTER ENGNR&CONSLTNG by Computer Engineering & Consulting Ltd

Computer Engineering & Consulting Ltd

CHINA MEIDONG AUTO HLDGS by China Meidong Auto Hldgs

China MeiDong Auto Holdings Ltd

CM ENERGY TECH CO LTD by CM ENERGY TECH CO LTD

CM Energy Tech Co Ltd

CREO MED GROUP LTD by CREO MED GROUP LTD.

Creo Medical Group PLC

CoinMerge (BEP-20)

CMONEY INC by cMoney, Inc.

On April 28, a recent SEC filing unveiled that Larry G Gerdes, Board Member at CME Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) made an insider sell.
What Happened: Gerdes's decision to sell 4,000 shares of CME Group was revealed in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0001156375/000115637525000100//Archives/edgar/data/1156375/000115637525000100/0001156375-25-000100-index.htm">U.S. Securities and Exchange Commission</a> on Monday. The total value of the sale is $1,060,441.
During Tuesday's morning session, CME Group shares up by 0.27%, currently priced at $268.63.
<h3>Unveiling the Story Behind CME Group</h3>
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&amp;P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&amp;P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.
<h3>Financial Insights: CME Group</h3>
Revenue Growth: CME Group displayed positive results in 3 months. As of 31 March, 2025, the company achieved a solid revenue growth rate of approximately 7.67%. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Financials sector.
Interpreting Earnings Metrics:
<ul>
<li>
Gross Margin: Achieving a high gross margin of 87.41%, the company performs well in terms of cost management and profitability within its sector.
</li>
<li>
Earnings per Share (EPS): CME Group's EPS is notably higher than the industry average. The company achieved a positive bottom-line trend with a current EPS of 2.63.
</li>
</ul>
Debt Management: With a below-average debt-to-equity ratio of 0.13, CME Group adopts a prudent financial strategy, indicating a balanced approach to debt management.
Evaluating Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: The Price to Earnings ratio of 26.95 is lower than the industry average, indicating potential undervaluation for the stock.
</li>
<li>
Price to Sales (P/S) Ratio: A higher-than-average P/S ratio of 15.35 suggests overvaluation in the eyes of investors, considering sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): CME Group's EV/EBITDA ratio, lower than industry averages at 19.05, indicates attractively priced shares.
</li>
</ul>
Market Capitalization: Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Illuminating the Importance of Insider Transactions</h3>
Insider transactions shouldn't be used primarily to make an investing decision, however, they can be an important factor for an investor to consider.
In legal terms, an "insider" refers to any officer, director, or beneficial owner of more than ten percent of a company's equity securities registered under Section 12 of the Securities Exchange Act of 1934. This can include executives in the c-suite and large hedge funds. These insiders are required to let the public know of their transactions via a Form 4 filing, which must be filed within two business days of the transaction.
When a company insider makes a new purchase, that is an indication that they expect the stock to rise.
Insider sells, on the other hand, can be made for a variety of reasons, and may not necessarily mean that the seller thinks the stock will go down. 
<h3>Understanding Crucial Transaction Codes</h3>
Surveying the realm of stock transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> often give prominence to those unfolding in the open market, systematically detailed in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C denotes the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001156375">Check Out The Full List Of CME Group's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Insider Trades

Trading Ideas

Larry G Gerdes Executes Sell Order: Offloads $1.06M In CME Group Stock

CME Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) has been analyzed by 17 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">5</td>
<td align="right">8</td>
<td align="right">3</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">4</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for CME Group, revealing an average target of $266.18, a high estimate of $305.00, and a low estimate of $211.00. Witnessing a positive shift, the current average has risen by 3.75% from the previous average price target of $256.56.
<img src="https://www.benzinga.com/files/images/story/2025/1745618427_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive CME Group. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;---------------------&#x7C;-----------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Alex Kramm &#x7C;UBS &#x7C;Raises &#x7C;Buy &#x7C; $305.00&#x7C;$290.00 &#x7C; 
&#x7C;Mike Cyprys &#x7C;Morgan Stanley &#x7C;Raises &#x7C;Overweight &#x7C; $304.00&#x7C;$301.00 &#x7C; 
&#x7C;Kyle Voigt &#x7C;Keefe, Bruyette &amp; Woods&#x7C;Raises &#x7C;Market Perform &#x7C; $273.00&#x7C;$265.00 &#x7C; 
&#x7C;Kenneth Worthington &#x7C;JP Morgan &#x7C;Lowers &#x7C;Underweight &#x7C; $211.00&#x7C;$223.00 &#x7C; 
&#x7C;Benjamin Budish &#x7C;Barclays &#x7C;Raises &#x7C;Equal-Weight &#x7C; $283.00&#x7C;$279.00 &#x7C; 
&#x7C;Owen Lau &#x7C;Oppenheimer &#x7C;Raises &#x7C;Outperform &#x7C; $279.00&#x7C;$269.00 &#x7C; 
&#x7C;Patrick Moley &#x7C;Piper Sandler &#x7C;Raises &#x7C;Overweight &#x7C; $283.00&#x7C;$275.00 &#x7C; 
&#x7C;Benjamin Budish &#x7C;Barclays &#x7C;Raises &#x7C;Equal-Weight &#x7C; $279.00&#x7C;$263.00 &#x7C; 
&#x7C;Ashish Sabadra &#x7C;RBC Capital &#x7C;Maintains &#x7C;Sector Perform &#x7C; $269.00&#x7C;$269.00 &#x7C; 
&#x7C;Craig Siegenthaler &#x7C;B of A Securities &#x7C;Raises &#x7C;Underperform &#x7C; $219.00&#x7C;$200.00 &#x7C; 
&#x7C;Patrick O'Shaughnessy&#x7C;Raymond James &#x7C;Announces &#x7C;Outperform &#x7C; $287.00&#x7C;- &#x7C; 
&#x7C;Mike Cyprys &#x7C;Morgan Stanley &#x7C;Raises &#x7C;Equal-Weight &#x7C; $263.00&#x7C;$256.00 &#x7C; 
&#x7C;Kyle Voigt &#x7C;Keefe, Bruyette &amp; Woods&#x7C;Raises &#x7C;Market Perform &#x7C; $257.00&#x7C;$256.00 &#x7C; 
&#x7C;Ashish Sabadra &#x7C;RBC Capital &#x7C;Raises &#x7C;Sector Perform &#x7C; $269.00&#x7C;$235.00 &#x7C; 
&#x7C;Owen Lau &#x7C;Oppenheimer &#x7C;Raises &#x7C;Outperform &#x7C; $269.00&#x7C;$258.00 &#x7C; 
&#x7C;Kenneth Worthington &#x7C;JP Morgan &#x7C;Raises &#x7C;Underweight &#x7C; $212.00&#x7C;$209.00 &#x7C; 
&#x7C;Benjamin Budish &#x7C;Barclays &#x7C;Raises &#x7C;Equal-Weight &#x7C; $263.00&#x7C;$257.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to CME Group. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of CME Group compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of CME Group's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/CME/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on CME Group analyst ratings.</a>
<h2>About CME Group</h2>
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&amp;P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&amp;P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.
<h3>CME Group: Financial Performance Dissected</h3>
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Revenue Growth: CME Group displayed positive results in 3M. As of 31 March, 2025, the company achieved a solid revenue growth rate of approximately 7.67%. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Financials sector.
Net Margin: CME Group's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 57.49%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 3.53%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): CME Group's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 0.64%, the company may face hurdles in achieving optimal financial performance.
Debt Management: CME Group's debt-to-equity ratio is below the industry average. With a ratio of 0.13, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>What Are Analyst Ratings?</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

Deep Dive Into CME Group Stock: Analyst Perspectives (17 Ratings)

UBS analyst Alex Kramm maintains CME Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) with a Buy and raises the price target from $290 to $305.

Price Target

UBS Maintains Buy on CME Group, Raises Price Target to $305

Derivatives traders aggressively bet on XRP's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>) price increase amid the announcement of the coin's futures contracts on CME Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) on Thursday.
What happened: More than 70.73% of traders on Binance with an open XRP position were positioned long, up from 67.57% a week ago, <a href="https://www.coinglass.com/LongShortRatio">according</a> to Coinglass.
It indicated that the number of individuals holding long positions in XRP was 2.42 times higher than those holding short positions.
Bullish expectations were also high among the top 20% of traders with the highest margin balance, with approximately 69.43% betting on XRP&#8217;s rally.
See Also:<a href="https://www.benzinga.com/25/04/44621245/gold-backed-cryptos-match-yellow-metals-highs-following-trumps-liberation-day-shock"> </a><a href="https://www.benzinga.com/25/04/44971891/sec-teams-up-with-nayib-bukele-led-el-salvador-for-a-crypto-regulatory-sandbox">SEC Zooms In On Nayib Bukele-Led El Salvador&#8217;s Crypto Regulation Model</a>
The Open Interest in XRP futures fell 1.74% in the last 24 hours but was up nearly 23% over the week, signaling a jump in leverage and speculative demand.
Why It Matters: The move comes as leading derivatives marketplace CME Group <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44984259/cme-group-to-launch-xrp-futures-in-may-how-did-xrp-price-react">announced an XRP futures offering</a>, allowing investors to profit from the coin&#8217;s volatility without directly holding it.
Traders will have access to two contract sizes: a micro contract (2,500 XRP) and a standard contract (50,000 XRP), and they will be cash-settled.
The buzz around investment vehicles seeking exposure to XRP, the fourth-largest cryptocurrency, has soared since Ripple Labs and the SEC <a href="https://www.benzinga.com/top-stories/25/04/44758705/ripple-sec-move-to-end-legal-dispute-as-both-sides-withdraw-appeals">agreed to a final resolution</a> of their lengthy legal feud.
As of this writing, the odds of an XRP exchange-traded fund approval in 2025 were 71% on Polymarket. Investment giants like Grayscale Investments, Franklin Templeton, and WisdomTree have <a href="https://www.benzinga.com/trading-ideas/movers/25/02/43720517/xrp-outshines-bitcoin-ethereum-after-sec-acknowledges-grayscale-etf-filing">filed applications</a> with the SEC to launch XRP ETFs.
Price Action: At the time of writing, XRP was exchanging hands at $2.17, down 1.15% in the last 24 hours, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA..">data from Benzinga Pro</a>.
Shares of CME Group rose 1.17% in after-hours trading after closing 0.68% higher at $263.27 during Thursday&#8217;s regular session. 
As of this writing, the CME stock has a high momentum score but a lower valuation. To check how your favorite stocks fare on these parameters, click on <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">Benzinga Edge Stock Rankings</a>. 
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="486" height="135" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/24232903/Screenshot-2025-04-25-085848.png" alt="" class="wp-image-887833" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/24232903/Screenshot-2025-04-25-085848.png 486w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/24232903/Screenshot-2025-04-25-085848-300x83.png 300w" sizes="(max-width: 486px) 100vw, 486px" /></figure>
Photo: alfernec/shutterstock
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44971214/solana-staking-etf-surges-18-in-debut-week-heres-how-much-cathie-woods-ark-invest-has-parked-in-it">Solana Staking ETF Surges 18% In Debut Week—Here&#8217;s How Much Cathie Wood&#8217;s Ark Invest Has Parked In It</a></li>
</ul>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Markets

$XRP

XRP Bullish Bets In Derivatives Market Surge As CME Group Announces Futures Offering

Morgan Stanley analyst Mike Cyprys maintains CME Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) with a Overweight and raises the price target from $301 to $304.

Morgan Stanley Maintains Overweight on CME Group, Raises Price Target to $304

Keefe, Bruyette &amp; Woods analyst Kyle Voigt maintains CME Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) with a Market Perform and raises the price target from $265 to $273.

Keefe, Bruyette & Woods Maintains Market Perform on CME Group, Raises Price Target to $273

JP Morgan analyst Kenneth Worthington maintains CME Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) with a Underweight and lowers the price target from $223 to $211.

JP Morgan Maintains Underweight on CME Group, Lowers Price Target to $211

Barclays analyst Benjamin Budish maintains CME Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) with a Equal-Weight and raises the price target from $279 to $283.

Barclays Maintains Equal-Weight on CME Group, Raises Price Target to $283

Risk-on sentiment dominated Wall Street on Wednesday, as upbeat earnings reports and conciliatory messages from the Trump administration h<a href="https://www.benzinga.com/markets">elped lift investor confidence.</a>
The administration eased market fears on two major fronts that have recently weighed heavily on sentiment. On the trade front, tensions with China appeared to thaw, with reports suggesting the White House is considering reducing tariffs on certain categories of goods.
U.S. Treasury Secretary Scott Bessent added fuel to the rally, stating U.S.-China tariffs are unsustainable and will likely need to be lowered to facilitate meaningful negotiations.
Meanwhile, President Donald Trump offered an abrupt shift in tone toward Federal Reserve Chair Jerome Powell, saying he has no intention to fire him, a remark that helped calm concerns over political interference in monetary policy.
By midday in New York, the S&amp;P 500 was up by nearly 2%, though it had earlier climbed even higher. The Nasdaq 100 outperformed with a 2.5% gain, driven by strength in Magnificent Seven stocks.
Trump's pivot on Powell pushed Treasury yields lower across the curve, with the 30-year yield falling five basis points to 4.83%, after briefly topping 4.90% the previous day.
On the macro front, flash Purchasing Managers&#8217; Index surveys revealed slowing growth momentum in the U.S. economy, as the services sector decelerated sharply following the impact <a href="https://www.benzinga.com/government/regulations/25/04/44952395/us-business-activity-growth-slows-in-april-as-services-suffer-tariff-shock-markets-rally-as-trade-war-cools">of recent tariff shocks.</a>
The U.S. dollar strengthened, while gold plunged 2.6%, heading for its worst session since November.
Oil prices dropped more than 2% following speculation that OPEC+ may announce a new output hike as early as next month.
Meanwhile, Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) held steady around $93,000.
<h1 class="wp-block-heading">Wednesday&#8217;s Performance In Major U.S. Indices, ETFs</h1>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>Chg</td>
<td>1-day %</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>18,732.09</td>
<td>+455.68</td>
<td>2.5%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>1,926.45</td>
<td>+37.40</td>
<td>2.0%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,384.67</td>
<td>+96.91</td>
<td>1.8%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>39,724.87</td>
<td>+537.89</td>
<td>1.4%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated at 12:35 p.m. ET</figcaption></figure>
According to&nbsp;<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">Benzinga Pro</a>&nbsp;data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) rose 1.9% to $537.35.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) rose 1.4% to $397.79.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)&nbsp;rallied 2.7% to $456.50.</li>
<li>The&nbsp;iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) soared 2.1% to $191.47.</li>
<li>The&nbsp;Technology&nbsp;Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>) outperformed, up 3.44%; the&nbsp;Consumer Staples&nbsp;Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLP#NYSE">XLP</a>) lagged, down 1.2%.</li>
</ul>
<h1 class="wp-block-heading">Wednesday&#8217;s Stock Movers</h1>
<ul>
<li>Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) jumped 6.6% despite falling short on both earnings and revenue expectations, as CEO Elon Musk reassured investors by pledging to scale back his involvement with DOGE and refocus on the company.</li>
</ul>
Other stocks reacting to earnings report included: 
<ul>
<li>Intuitive Surgical Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>): up 2.8%</li>
<li>Chubb Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CB#NYSE">CB</a>): down 2.6%</li>
<li>Capital One Financial Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COF#NYSE">COF</a>): up 4.6%</li>
<li>Steel Dynamics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STLD#NASDAQ">STLD</a>): up 4.7%</li>
<li>EQT Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQT#NYSE">EQT</a>): up 3%</li>
<li>Packaging Corporation of America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PKG#NYSE">PKG</a>): down 1.7%</li>
<li>Baker Hughes Co. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKR#NASDAQ">BKR</a>): down 4.3%</li>
<li>Enphase Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NASDAQ">ENPH</a>): down 14.4%​</li>
<li>Thermo Fisher Scientific Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TMO#NYSE">TMO</a>): down 0.5%</li>
<li>Philip Morris International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>): up 2.6%</li>
<li>NextEra Energy, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEE#NYSE">NEE</a>): up 1%</li>
<li>Boston Scientific Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSX#NYSE">BSX</a>): up 4.8%</li>
<li>General Dynamics Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GD#NYSE">GD</a>): down 3.4%</li>
<li>Boeing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>): up 5.7%</li>
<li>Norfolk Southern Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NSC#NYSE">NSC</a>): up 1.4%</li>
<li>CME Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>): down 3.8%</li>
<li>TE Connectivity Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TEL#NYSE">TEL</a>): up 2.7%</li>
<li>Amphenol Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APH#NYSE">APH</a>): up 9.9%</li>
<li>AT&amp;T Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/T#NYSE">T</a>): up 0.8%</li>
<li>Old Dominion Freight Line, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ODFL#NASDAQ">ODFL</a>): up 1.3%</li>
<li>Westinghouse Air Brake Technologies Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WAB#NYSE">WAB</a>): up 7.2%</li>
<li>Masco Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAS#NYSE">MAS</a>): down 2.1%</li>
<li>Avery Dennison Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVY#NYSE">AVY</a>): down 2.4%</li>
<li>Lennox International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LII#NYSE">LII</a>): down 8.2%</li>
<li>GE Vernova Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>): up 5.2%</li>
<li>Teledyne Technologies Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDY#NYSE">TDY</a>): down 1.7%</li>
<li>Otis Worldwide Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OTIS#NYSE">OTIS</a>): down 6%​</li>
</ul>
<ul>
<li>Stocks slated to report earnings after the bell include Chipotle Mexican Grill, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMG#NYSE">CMG</a>), O'Reilly Automotive, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORLY#NASDAQ">ORLY</a>), Raymond James Financial, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RJF#NYSE">RJF</a>), Molina Healthcare, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOH#NYSE">MOH</a>), Texas Instruments Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>), FirstEnergy Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FE#NYSE">FE</a>), ServiceNow, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>), Lam Research Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRCX#NASDAQ">LRCX</a>), Resmed Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RMD#NYSE">RMD</a>), Discover Financial Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DFS#NYSE">DFS</a>), International Business Machines Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBM#NYSE">IBM</a>), Newmont Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEM#NYSE">NEM</a>), Rollins Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ROL#NYSE">ROL</a>), United Rentals Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/URI#NYSE">URI</a>), Tyler Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TYL#NYSE">TYL</a>), Edwards Lifesciences Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EW#NYSE">EW</a>), Las Vegas Sands Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LVS#NYSE">LVS</a>), and Alaska Air Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALK#NYSE">ALK</a>).</li>
</ul>
Read Now: 
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/04/44948932/goldman-sachs-backs-copper-tariff-trade-if-trump-slaps-25-duty-on-us-imports">Goldman Sachs Backs &#8216;Copper Tariff Trade&#8217; If Trump Slaps 25% Duty On US Imports</a></li>
</ul>
Photo: Shutterstock

Equities

Government

Large Cap

Macro Economic Events

Regulations

Broad U.S. Equity ETFs

Economics

Federal Reserve

Tech

ETFs

$BTC

SPDR Dow Jones Industrial Average ETF Trust

ENPH

ISRG

LRCX

ODFL

ORLY

OTIS

STLD

TSLA

Select Sector SPDR-Consumer Discretionary

Stocks Surge On China Tariff Hopes, Tesla Jumps, Gold Loses Shine: What's Driving Markets Wednesday?

WIIM

CME Group shares are trading lower after the company reported worse-than-expected Q1 revenue results.

CME Group CEO Says 'Amid heightened economic uncertainty, CME Group operated with exceptional resilience'

Earnings

Earnings Beats

Earnings Misses

CME Gr Q1 Adj. EPS $2.80 Beats $2.79 Estimate, Sales $1.60B Miss $1.64B Estimate

AMTB

ASGN

BANC

BPOP

BRKL

BWFG

CACI

CBAN

CHDN

CHKP

COOP

CSLR

CVLG

New Oriental Education & Technology Group

EGBN

EPRT

GATX

GLPG

GSHD

HBNC

HCSG

IMAX

INBK

KALU

KREF

MTDR

OSBC

PLXS

PTEN

SEIC

Earnings Scheduled For April 23, 2025

CME Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) will release its quarterly earnings report on Wednesday, 2025-04-23. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate CME Gr to report an earnings per share (EPS) of $2.75.
The market awaits CME Gr's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
<h3>Overview of Past Earnings</h3>
The company's EPS beat by $0.07 in the last quarter, leading to a 0.46% increase in the share price on the following day.
Here's a look at CME Gr's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>2.45</td>
<td>2.65</td>
<td>2.53</td>
<td>2.45</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>2.52</td>
<td>2.68</td>
<td>2.56</td>
<td>2.50</td>
</tr>
<tr>
<td>Price Change %</td>
<td>0.0%</td>
<td>1.0%</td>
<td>1.0%</td>
<td>-0.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1745330509_0.png" alt="eps graph" />
<h3>Performance of CME Gr Shares</h3>
Shares of CME Gr were trading at $260.33 as of April 21. Over the last 52-week period, shares are up 24.05%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. 
<h3>Analyst Opinions on CME Gr</h3>
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on CME Gr.
Analysts have provided CME Gr with 12 ratings, resulting in a consensus rating of Neutral. The average one-year price target stands at $262.42, suggesting a potential 0.8% upside.
<h3>Comparing Ratings with Peers</h3>
The following analysis focuses on the analyst ratings and average 1-year price targets of Intercontinental Exchange, Moodys and S&amp;P Global, three prominent industry players, providing insights into their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Buy trajectory for Intercontinental Exchange, with an average 1-year price target of $200.0, suggesting a potential 23.17% downside.</li>
<li>Analysts currently favor an Neutral trajectory for Moodys, with an average 1-year price target of $525.38, suggesting a potential 101.81% upside.</li>
<li>Analysts currently favor an Outperform trajectory for S&amp;P Global, with an average 1-year price target of $605.25, suggesting a potential 132.49% upside.</li>
</ul>
<h3>Summary of Peers Analysis</h3>
The peer analysis summary provides a snapshot of key metrics for Intercontinental Exchange, Moodys and S&amp;P Global, illuminating their respective standings within the industry. These metrics offer valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>CME Group</td>
<td>Neutral</td>
<td>5.98%</td>
<td>$1.30B</td>
<td>3.16%</td>
</tr>
<tr>
<td>Intercontinental Exchange</td>
<td>Buy</td>
<td>13.65%</td>
<td>$1.62B</td>
<td>2.54%</td>
</tr>
<tr>
<td>Moodys</td>
<td>Neutral</td>
<td>12.97%</td>
<td>$1.18B</td>
<td>10.58%</td>
</tr>
<tr>
<td>S&amp;P Global</td>
<td>Outperform</td>
<td>13.96%</td>
<td>$2.48B</td>
<td>2.62%</td>
</tr>
</tbody>
</table>

Key Takeaway:
CME Group ranks in the middle among its peers for revenue growth. It is at the bottom for gross profit and return on equity.
<h3>All You Need to Know About CME Gr</h3>
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&amp;P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&amp;P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.
<h3>Financial Milestones: CME Gr's Journey</h3>
Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.
Positive Revenue Trend: Examining CME Gr's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 5.98% as of 31 December, 2024, showcasing a substantial increase in top-line earnings. When compared to others in the Financials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: CME Gr's net margin is impressive, surpassing industry averages. With a net margin of 56.62%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): CME Gr's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 3.16%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): CME Gr's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 0.63%, the company may face hurdles in achieving optimal financial returns.
Debt Management: CME Gr's debt-to-equity ratio is below the industry average. With a ratio of 0.13, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<a href="https://www.benzinga.com/quote/CME/earnings">To track all earnings releases for CME Gr visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Preview For CME Gr

KKR &amp; Co. Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KKR#NYSE">KKR</a>) shares are trading higher on Monday. S&amp;P Global Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPGI#NYSE">SPGI</a>) and CME Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) inked a deal to sell OSTTRA to investment funds managed by KKR at a <a href="https://www.benzinga.com/pressreleases/25/04/n44785236/s-p-global-and-cme-group-to-sell-osttra-to-kkr-for-3-1-billion" target="_blank" rel="noreferrer noopener">total enterprise value of $3.1 billion</a>.
Formed in 2021 through a joint venture between CME and S&amp;P Global, OSTTRA delivers essential post-trade services to the global financial industry.
OSTTRA supports the full trade lifecycle—enabling seamless connectivity and efficient workflows for banks, broker-dealers, asset managers, and other market participants across trade processing and optimization.
As equal partners in the joint venture, S&amp;P Global and CME Group will split the proceeds from the sale equally.
Notably, KKR is acquiring OSTTRA primarily through its North American private equity platform.
Upon completion of the transaction, KKR intends to implement a broad-based equity ownership plan, allowing nearly all of OSTTRA's approximately 1,500 employees to share in the company's future growth.
The deal is expected to close in the second half of 2025, pending regulatory approvals and other customary closing conditions.
Guy Rowcliffe and John Stewart, co-CEOs of OSTTRA said, &#8220;With KKR&#8217;s support, we will further accelerate our strategic initiatives to enhance our market-leading post-trade solutions, drive innovation, and expand our global footprint.&#8221;
Last week, KKR secured a deal to acquire Swedish consumer health firm&nbsp;Karo Healthcare, which is expected to be valued at around 2.65 billion <a target="_blank" href="https://www.benzinga.com/markets/equities/25/04/44725000/kkr-outbids-competitors-to-secure-2-9-billion-karo-healthcare-takeover" rel="noreferrer noopener">euros ($2.924 billion), including debt</a>.
KKR plans to release first-quarter <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">FY25 results on May 1, 2025</a>.
Investors can gain exposure to KKR via FM Focus Equity ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMCX#NYSE">FMCX</a>) and EA Series Trust WHITEWOLF Publicly Listed Private Equity ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/LBO#BATS">LBO</a>).
Price Action: KKR shares are up 1.25% at $102.71 at last check Monday.
Read Next:&nbsp;&nbsp;
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/44634677/goldman-sachs-sees-broad-eps-pressure-across-capital-markets-highlights-brookfield-as-a-standout" target="_blank" rel="noreferrer noopener">Goldman Sachs Sees Broad EPS Pressure Across Capital Markets, Highlights Brookfield As A Standout</a></li>
</ul>
Photo: Shutterstock

Movers

Northern Lights Fund Trust IV FMC Excelsior Focus Equity ETF

FMCX

SPGI

KKR Targets Backbone Of Global Trading With $3.1 Billion OSTTRA Acquisition

April 11, 2025 records indicate that Representative Carol Miller filed a purchase of Aflac (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AFL#NYSE">AFL</a>), valued between $9,009 and $135,000. According to the April filing, the transaction occurred on April 11, 2025.
Currently, Aflac shares are trading up 2.42% at $109.41.
<h3>Representative's Recent Trading Activity</h3>
In the last three years, Carol Miller completed 55 stock transactions totaling more than $546 thousand. Texas Instruments and Emerson Electric stocks were among the largest trades. Some of the most notable transactions the Rep. has executed recently include: 
<ul>
<li>Aflac (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AFL#NYSE">AFL</a>): $1,001 - $15,000 Purchase</li>
<li>American Water Works Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AWK#NYSE">AWK</a>): $1,001 - $15,000 Purchase</li>
<li>CME Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>): $1,001 - $15,000 Purchase</li>
</ul>
Here's a summary of Carol Miller's recent trades:
<table>
<thead>
<tr>
<th>Company</th>
<th>Ticker</th>
<th>Stock Type</th>
<th>Amount</th>
<th>Transaction Type</th>
<th>Transaction Date</th>
</tr>
</thead>
<tbody>
<tr>
<td>Aflac</td>
<td>AFL</td>
<td>STOCK</td>
<td>$1,001 - $15,000</td>
<td>P</td>
<td>2025-03-10</td>
</tr>
<tr>
<td>American Water Works Co</td>
<td>AWK</td>
<td>STOCK</td>
<td>$1,001 - $15,000</td>
<td>P</td>
<td>2025-03-10</td>
</tr>
<tr>
<td>CME Group</td>
<td>CME</td>
<td>STOCK</td>
<td>$1,001 - $15,000</td>
<td>P</td>
<td>2025-03-10</td>
</tr>
<tr>
<td>Gilead Sciences</td>
<td>GILD</td>
<td>STOCK</td>
<td>$1,001 - $15,000</td>
<td>P</td>
<td>2025-03-10</td>
</tr>
<tr>
<td>Honeywell Intl</td>
<td>HON</td>
<td>STOCK</td>
<td>$1,001 - $15,000</td>
<td>P</td>
<td>2025-03-10</td>
</tr>
</tbody>
</table>
Want to keep up with Carol Miller and other congressional members' stock activities? Check out our <a href="https://www.benzinga.com/gov-trades/members/carol-miller">government trades tool</a> for real-time updates!
<h3>The Importance of Congressional Transactions</h3>
A congressional transaction is when any representative or senator either buys or sells an individual stock.
Anyone working in Congress must file a Periodic Transaction Report to inform the public of their recent transaction within 30 days of being notified of the transaction and within 45 days of the transaction date.
In April 2012, Former President Barack Obama signed the STOCK Act into law. The act prohibits members of Congress from using private information given to them by their position for personal gain such as buying or selling a stock. The act also expanded disclosure requirements for members of Congress by requiring them to file a monthly disclosure.
<h3>Why Congressional Transactions Matter</h3>
Congressional transactions shouldn't be the primary reason for an investing decision, but they can be an important factor for an investor to consider.
When a senator or representative makes a new purchase, it could be an indication they expect the stock to rise.
A sale, on the other hand, can be made for a variety of reasons, and may not necessarily mean the seller thinks the stock will go down.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Politics

General

West Virginia Rep. Carol Miller Bought Up to $135K Worth of Aflac Stock

S&amp;P Global and CME Group today announced the signing of a definitive agreement to sell OSTTRA, a leading provider of post-trade solutions for the global OTC market, to investment funds managed by KKR, a leading global investment firm.&nbsp; The terms of the deal for OSTTRA equaled total enterprise value at $3.1 billion, subject to customary purchase price adjustments, which will be divided evenly between S&amp;P Global and CME Group pursuant to their 50/50 joint venture.
&nbsp;
Established in 2021 as a joint venture between CME Group and S&amp;P Global, OSTTRA serves the global financial ecosystem with a comprehensive suite of critical post-trade offerings across interest rates, FX, credit and equity asset classes. OSTTRA provides end-to-end connectivity and workflow solutions to banks, broker-dealers, asset managers, and other market participants across trade processing, trade lifecycle, and optimization.
The OSTTRA management team, led by co-CEOs&nbsp;Guy Rowcliffe and John Stewart, will continue to lead the company in their current roles. KKR will support OSTTRA's customer-centric growth and role as a critical market infrastructure provider by increasing OSTTRA's investments in technology and innovation across its leading post-trade solutions platform.

Asset Sales

S&P Global and CME Group Sell OSTTRA to KKR for $3.1B, Focused on Post-Trade Solutions Growth

Companies with a long history of paying dividends and consistently hiking them remain appealing to income-focused investors. Regency Centers, CME Group, and Trinity Industries have rewarded shareholders for years and recently announced dividend increases. These companies currently offer dividend yields of over 4%.
Regency Centers
Regency Centers Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REG#NASDAQ">REG</a>) is national owner, operator, and developer of shopping centers located in suburban trade areas with compelling demographics.
Don't Miss:
<ul>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> this is your last chance to become an investor for $0.80 per share.</a></li>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.26/share!</a></li>
</ul>
The company has increased its dividends every year for the last 11 years. In its most recent dividend hike announcement on Nov. 7, its board raised the quarterly payout by 5.2% to $0.705 per share, which is equal to an annual figure of $2.82 per share. Currently, the dividend yield stands at 4.18%.
Regency Centers' annual revenue as of Dec. 31 stood at $1.45 billion. As per the company's Q4 2024 earnings release on Feb. 6, it posted revenues of $372.54 million and EPS of $1.09, both coming in above the Street estimates.
Trending: <a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.
CME Group
CME Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) operates contract markets for the trading of futures and options on futures contracts worldwide.
CME Group has increased its dividends consecutively for the last 14 years. In its latest dividend announcement on Feb. 5, the company's board approved a 9% increase in the quarterly payout, raising it to $1.25 per share. This comes on top of the annual variable dividend of $5.80 per share, bringing the total annualized dividend to $10.80 per share. Currently, the dividend yield on the stock is 4.28%.
The company's annual revenue as of Dec. 31 stood at $6.13 billion. In its Q4 2024 earnings release on Feb. 12, it posted revenues of $1.52 billion and EPS of $2.52, both beating market expectations.
Check out this <a href="https://www.benzinga.com/insights/analyst-ratings/25/04/44612649/12-analysts-have-this-to-say-about-cme-group">article by Benzinga</a> for 12 analysts&#8217; insights on CME Group.
See Also: Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">invest pre-IPO from $0.55 per share now</a>.
Trinity Industries
Trinity Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRN#NYSE">TRN</a>) provides railcar products and services under the TrinityRail trade name in North America.
Trinity Industries has raised its dividends every year since 2011. According to its most recent dividend hike announcement on Dec. 5, the company increased the quarterly payout from $0.28 to $0.30 per share, equaling $1.20 per share annually. Currently, the dividend yield on the stock is 4.81%.
The company's annual revenue as of Dec. 31 stood at $3.08 billion. In its most recent earnings report on Feb. 20, it posted Q4 2024 revenues of $629.40 million and EPS of $0.39. Both figures came in above the consensus estimates.
Regency Centers, CME Group, and Trinity Industries are good choices for investors seeking reliable passive income. Their dividend yields of over 4% and long history of consistent hikes make them attractive to income-focused investors.
Check out this <a href="https://www.benzinga.com/personal-finance/25/04/44667710/how-comcast-polaris-and-federal-agricultural-mortgage-can-put-cash-in-your-pocket">article by Benzinga</a> for three more stocks offering high dividend yields.
Read Next:
<ul>
<li>BlackRock is calling 2025 the year of alternative assets. <a href="https://www.benzinga.com/money/masterworks">One firm from NYC has quietly built a group of 60,000+ investors who have all joined in on an alt asset class previously exclusive to billionaires like Bezos and Gates.</a></li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
</ul>

Personal Finance

Why Regency Centers, CME Group, And Trinity Industries Are Winners For Passive Income

Oppenheimer analyst Owen Lau maintains CME Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) with a Outperform and raises the price target from $269 to $279.

Oppenheimer Maintains Outperform on CME Group, Raises Price Target to $279

Piper Sandler analyst Patrick Moley maintains CME Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) with a Overweight and raises the price target from $275 to $283.

Piper Sandler Maintains Overweight on CME Group, Raises Price Target to $283

Press Releases

Producer sentiment slips due to rising policy uncertainty

CME Group Sets New, All-Time Quarterly ADV Record of 29.8 Million Contracts, Driven by Growth Across All Asset Classes

Fintech

CME Group to Launch Spot-Quoted Futures, Providing Innovative New Trading Opportunities for Retail Investors

CME Group International Average Daily Volume Hits Record 8.8 Million Contracts in Q1 2025, Up 19% Year over Year

S&P Global and CME Group to sell OSTTRA to KKR for $3.1 billion

/C O R R E C T I O N -- S&P Global/

Sterling Trading Tech Names Julie Armstrong Chief Commercial Officer

CME Group Inc. Reports All-Time Record Revenue, Adjusted Operating Income, Adjusted Net Income and Adjusted Earnings Per Share for Q1 2025

CME Clearing Appoints New Chief Risk Officer

CME Group to Expand Crypto Derivatives Suite with Launch of XRP Futures

AGM Group Holdings Inc. - Class A Ordinary Shares

AGM Gr Hldgs

Aether Holdings

Bakkt Holdings, Inc. Class A Common Stock

Bakkt Hldgs

Coincheck Group

Coinbase Global, Inc. - Class A Common Stock

Coinbase Global

Donnelley Financial Solutions, Inc. Common Stock

Donnelley Financial Solns

FactSet Research Systems Inc. Common Stock

FactSet Research Systems

Intercontinental Exchange Inc. Common Stock

Intercontinental Exchange

Open Lending

Moodys

Marketwise

MarketAxess Holdings, Inc. - Common Stock

MarketAxess Holdings

Morningstar

MSCI

Nasdaq

Powell Max Limited - Class A Ordinary Shares

Powell Max

S&P Global

Tradeweb Markets Inc. - Class A Common Stock

Comments

CME Group

ニュース

パートナーシップ

ベンジンガ・グローバル